title: Allosteric modulation of the M₃ muscarinic receptor by amiodarone and N-ethylamiodarone: application of the four-ligand allosteric two-state model.
abstract: We have reported previously that amiodarone interacts with muscarinic receptors via a novel allosteric site. This study presents mechanistic details on the nature of that interaction. Amiodarone enhanced the maximal level of agonist-stimulated release of arachidonic acid (AA) from Chinese hamster ovary cells that expressed M₃ muscarinic receptors; this enhancement was observed for acetylcholine and for the partial agonist pilocarpine. A similar effect of amiodarone was observed when pilocarpine was used to stimulate inositol phosphate (IP) metabolism, but not when acetylcholine was used. Subsequent studies showed that the IP response exhibited a much larger receptor reserve than the AA response, and reduction of that reserve by receptor alkylation unmasked amiodarone's enhancement of the maximal IP response to acetylcholine. Modulating the receptor reserve also revealed acetylcholine's greater affinity (K(A)) for the conformation of the receptor that mediates the AA response. The amiodarone analog N-ethylamiodarone (NEA) did not alter maximal agonist response but merely reduced agonist potency (that is, it appeared to be an antagonist). However, the action of NEA could be clearly distinguished from the action of the orthosteric antagonist NMS. Demonstration of this point was facilitated by an elaboration of Hall's allosteric two-state model; this new model represents a system composed of two ligands that compete with each other at the orthosteric site and two ligands that compete with each other at the allosteric site. In conclusion, amiodarone competes with NEA at a novel, extracellular, allosteric site to enhance the maximal stimulation evoked by acetylcholine and pilocarpine in two different responses.
authors: Department of Psychiatry, the Penn State University College of Medicine, Hershey, Pennsylvania, USA.
authors: Edward
authors: E
authors: Stahl
authors: Gwendolynne
authors: G
authors: Elmslie
authors: John
authors: J
authors: Ellis
references: Mol Pharmacol. 1998 Jul;54(1):94-104
references: 9658194
references: J Pharmacol Exp Ther. 2010 Jul;334(1):214-22
references: 20348203
references: Bioorg Med Chem Lett. 2008 Jul 15;18(14):4098-101
references: 18550372
references: J Pharmacol Exp Ther. 2003 Oct;307(1):322-30
references: 12954816
references: Mol Pharmacol. 1988 Feb;33(2):187-94
references: 2828914
references: Mol Pharmacol. 2005 Nov;68(5):1484-95
references: 16113085
references: Mol Pharmacol. 1999 Mar;55(3):453-61
references: 10051528
references: Br J Pharmacol. 2010 Nov;161(6):1276-90
references: 20977467
references: Mol Pharmacol. 2000 Dec;58(6):1451-60
references: 11093785
references: Mol Pharmacol. 2009 Mar;75(3):577-88
references: 19047481
references: Mol Pharmacol. 1996 Jan;49(1):112-22
references: 8569696
references: Br J Pharmacol. 1993 Aug;109(4):946-52
references: 8401947
references: Br J Pharmacol. 1993 Sep;110(1):239-44
references: 8220884
references: Proc Natl Acad Sci U S A. 1988 Nov;85(22):8698-702
references: 2847172
references: J Theor Biol. 1996 Aug 21;181(4):381-97
references: 8949584
references: Biochem Pharmacol. 1999 Jan 15;57(2):181-6
references: 9890566
references: Trends Pharmacol Sci. 1995 Mar;16(3):89-97
references: 7540781
references: ACS Chem Biol. 2008 Sep 19;3(9):530-41
references: 18652471
references: Mol Pharmacol. 2000 Dec;58(6):1412-23
references: 11093781
references: Mol Pharmacol. 1983 May;23(3):551-7
references: 6865905
references: Proc Natl Acad Sci U S A. 1986 Oct;83(19):7201-5
references: 3020540
references: J Med Chem. 2009 Jun 11;52(11):3445-8
references: 19438238
references: Annu Rev Pharmacol Toxicol. 2007;47:1-51
references: 17009927
references: Pharmacol Rev. 1955 Jun;7(2):183-265
references: 13245382
references: Nat Rev Drug Discov. 2007 Sep;6(9):721-33
references: 17762886
references: Mol Pharmacol. 2003 Jul;64(1):180-90
references: 12815174
references: Am J Physiol Heart Circ Physiol. 2006 Mar;290(3):H948-58
references: 16183725
references: J Neurochem. 2003 Aug;86(4):980-91
references: 12887695
references: Brain Res. 1990 Mar 19;511(2):234-40
references: 2159358
references: J Pharmacol Exp Ther. 2003 Jan;304(1):229-37
references: 12490596
references: Cell Signal. 1999 Jun;11(6):405-13
references: 10400314
references: Br J Pharmacol. 2001 Feb;132(4):950-8
references: 11181437
references: Pharmacol Rev. 2002 Jun;54(2):323-74
references: 12037145
references: Pharmacol Ther. 2008 Feb;117(2):232-43
references: 18082893
references: Nat Chem Biol. 2008 Jan;4(1):42-50
references: 18059262
references: J Pharmacol Exp Ther. 2005 Nov;315(2):740-54
references: 16046613